Improving Pump Function and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Challenges and Opportunities
March 23, 2022
In this program, HF experts will provide insights into mechanisms and clinical evidence for improving myocardial contractility, and emphasize the need for a more personalized treatment of HFrEF to optimize patient outcomes.
No Credit Available
SGLT2 Inhibition and Heart Failure: Translating the Evidence to Clinical Practice
March 19, 2022
Information on best uses of SGLT2 inhibitors for patients with HF will be disseminated through lecture, interactive case presentation, panel discussion, and question-and-answer with experts.
No Credit Available
Keys to Prevention and Risk Reduction with Antiplatelet Therapy in Patients with Acute Ischemic Stroke and Transient Ischemic Attack
March 13, 2022
In this program, Chair Dr. S. Claiborne Johnston, Dr. Brett Cucchiara, Dr. Louise McCullough, and Dr. Carlos Molina will interpret the evidence for DAPT, provide insights into the choice of clopidogrel or ticagrelor to add to ASA, describe deficiencies in care preventing optimal use of DAPT, and explain remedies.
No Credit Available
Managing the Heart Failure Patient with Reduced Ejection Fraction: New Perspectives and Emerging Evidence
November 13, 2021
In this program, HF experts will provide insights into mechanisms for improving myocardial contractility and clinical evidence and emphasize the need for a more personalized treatment of HFrEF.
No Credit Available
Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes
November 04, 2021
This program will address challenges for interventional cardiologists in using antiplatelet therapy, with the overarching focus on balancing the need to reduce ischemic risk and lower bleeding risk.
No Credit Available
2021 MASE Chapter Meeting
October 17, 2021
In this educational initiative, an expert in the management of Cushing’s disease will describe best practices for diagnosis and treatment to improve long-term outcomes for patients.
No Credit Available
Insights into Using Dual Antiplatelet Therapy in Patients with Acute Ischemic Stroke and Transient Ischemic Attack
October 16, 2021
In this program, experts in the management of stroke with antiplatelet therapy will interpret clinical trial evidence and identify patients for use of DAPT.
No Credit Available
Antiplatelet Therapy in Patients With Coronary Artery Disease and Acute Ischemic Stroke/ Transient Ischemic Attack: A Personalized Approach
July 28, 2021
In this program, experts in the use of antiplatelet therapy in CAD and acute ischemic stroke/TIA will describe best uses of antiplatelet therapy to optimize clinical outcomes in these settings.
No Credit Available
Reducing Cardiovascular Risk With PCSK9 Inhibitors in Patients With Recent Acute Coronary Syndromes
July 10, 2021
In this program, lipid expert Dr. James Underberg will describe best practices with PCSK9 inhibitors in patients who have experienced an ACS.
No Credit Available
From Glycemic Control to Cardiorenal Protection: Improving Outcomes With SGLT2 Inhibitors
May 15, 2021
Experts Dr. Lawrence Leiter (Chair), Dr. Jennifer Green, Dr. Javed Butler, and Dr. David Cherney from multiple specialties (endocrinology, cardiology, and nephrology) will through lecture, case presentations, and panel discussion, provide perspectives on translating evidence into clinical practice and indicate considerations for using SGLT2 inhibitors safely and effectively in patients with, and at high risk for CV disease, HF, and chronic kidney disease (CKD).
No Credit Available
Practices for Managing Excessive Daytime Sleepiness in Patients with Narcolepsy and Obstructive Sleep Apnea
August 23, 2020
Practices for Managing Excessive Daytime Sleepiness in Patients with Narcolepsy and Obstructive Sleep Apnea
No Credit Available
Narcolepsy and Excessive Daytime Sleepiness in OSA: Strategies to Improving Outcomes
January 26, 2020
In this program, sleep experts Dr. Richard Bogan (Chair), Dr. Yves Dauvilliers, Dr. Kiran Maski, Dr. Paula Schweitzer, and Dr. Michael Thorpy assess traditional and new therapies for treating patients with narcolepsy and EDS in OSA.
No Credit Available